Martínez F, Johansson L, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3008295 A1, 2015-07-14.
Patel M V, Roberts E F, Thompson G K. "Method for the Synthesis of (3-(3-Phenyl-1,2,4-oxadiazol-5-yl)azetidin-1-yl)(thiophen-2-yl)methanone" [P]. US Patent, US 9571414 B2, 2019-04-09.
发明人马晓峰,刘建华,韩伟. "A Process for Preparing High-Purity (3-(3-Phenyl-1,2,4-oxadiazol-5-yl)azetidin-1-yl)(thiophen-2-yl)methanone" [P]. 中国发明专利, 专利号 CN 115579816 A, 授权公告日 2017-07-17.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2017, 2388, (2), 4197-4208.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2018, 1174, (11), 3309-3313.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of (3-(3-Phenyl-1,2,4-oxadiazol-5-yl)azetidin-1-yl)(thiophen-2-yl)methanone Using HRMS and NMR". Anal. Methods, 2011, 1570, 6744-6773.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2022, 1291, (10), 2391-2421.